IFNA1 and systemic lupus erythematosus: The earliest evidence suggesting that type one interferon could play a key role in the genesis of SLE in humans, came from the observation that patients treated with IFNα for hepatitis C [130] or neoplastic disease [131,132], could develop antinuclear antibody positivity and in some cases lupus-like syndromes.